Mark Fishman
Mark Fishman | |
|---|---|
| Citizenship | United States |
| Alma mater | Yale College, Harvard Medical School |
| Known for | pioneering Zebrafish research in cardiology |
| Awards | Institute of Medicine member, Fellow of the American Academy of Arts and Sciences |
| Scientific career | |
| Fields | Medicine, Cardiology |
| Institutions | Novartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School |
Mark Fishman is an American cardiologist, a professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service service at the Massachusetts General Hospital for patients with complex medical disorders.[1] A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),[2] the main research arm of Novartis Pharmaceuticals.[3]
Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[4] He is the author of over 100 publications[5] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[6][7][8]
Education
[edit | edit source]- B.A. Yale College, 1972
- M.D. Harvard Medical School, 1976
Career
[edit | edit source]He was previously a professor of medicine at Harvard Medical School, chief of cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.[9]
After being the head of Novartis’ research operation for 13 years, he decided to retire in 2016[10] and became professor at Harvard and Chief at MGH[1]
References
[edit | edit source]- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ https://www.pubmed.gov 183 results as of 20 Oct 2009
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
External links
[edit | edit source]- Novartis Institutes for BioMedical Research Official Homepage
- Novartis Institutes for BioMedical Research Official Homepage Archived 2011-01-06 at the Wayback Machine
- Mark Fishman on changing the grammar of drug discovery
Lua error in Module:Authority_control at line 153: attempt to index field 'wikibase' (a nil value).
- Living people
- American medical researchers
- American cardiologists
- American businesspeople in the pharmaceutical industry
- American business executives
- Yale College alumni
- Harvard Medical School alumni
- Harvard Medical School faculty
- Fellows of the American College of Cardiology
- Members of the National Academy of Medicine
- Novartis people